Two Sigma Investments, LP Arcturus Therapeutics Holdings Inc. Transaction History
Two Sigma Investments, LP
- $42.3 Billion
- Q3 2024
A detailed history of Two Sigma Investments, LP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 17,130 shares of ARCT stock, worth $275,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,130
Previous 13,318
28.62%
Holding current value
$275,279
Previous $324,000
22.53%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ARCT
# of Institutions
172Shares Held
25.1MCall Options Held
195KPut Options Held
133K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$75.4 Million0.25% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$42.6 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$33.2 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$33.2 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$31.1 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $427M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...